🇺🇸 FDA
Patent

US 9156890

HCV vaccines and methods for using the same

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 9156890 (HCV vaccines and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/55